Calimeri T, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Steffanoni S, Foppoli M, Celico C, Falautano M, Nonis A, La Rosee P, Binder M, Fabbri A, Ilariucci F, Krampera M, Roth A, Hemmaway C, Johnson PW, Linton KM, Pukrop T, Sonderskov Gorlov J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Zanni M, Krause S, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Thurner L, Cabras G, Pennese E, Ponzoni M, Deckert M, Politi LS, Finke J, Ferranti A, Cozens K, Burger E, Ielmini N, Cavalli F, Zucca E, Illerhaus G, Ferreri AJM (2021)
Publication Type: Conference contribution
Publication year: 2021
Publisher: FERRATA STORTI FOUNDATION
City/Town: PAVIA
Pages Range: 33-33
Conference Proceedings Title: HAEMATOLOGICA
APA:
Calimeri, T., Cwynarski, K., Pulczynski, E., Fox, C.P., Schorb, E., Steffanoni, S.,... Ferreri, A.J.M. (2021). RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA. In HAEMATOLOGICA (pp. 33-33). PAVIA: FERRATA STORTI FOUNDATION.
MLA:
Calimeri, T., et al. "RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA." Proceedings of the HAEMATOLOGICA PAVIA: FERRATA STORTI FOUNDATION, 2021. 33-33.
BibTeX: Download